Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Roy

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The New England Journal of Medicine|November 28, 1991
Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphomaJ G Gribben, A S Freedman, D Neuberg, et al.
Bone Marrow Transplantation|December 23, 2015
Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantationI Ahmad, R LeBlanc, S Cohen, et al.
Bone Marrow Transplantation|January 10, 2002
Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effectR Le Blanc, S Montminy-Métivier, R Bélanger, et al.
Leukemia|May 15, 2013
Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic targetJ G Harb, P Neviani, B J Chyla, et al.
Leukemia|February 10, 2016
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancersD P Granados, A Rodenbrock, J-P Laverdure, et al.
Nature Genetics|October 3, 1999
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaW J Song, M G Sullivan, R D Legare, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The New England Journal of Medicine|November 28, 1991
Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphomaJ G Gribben, A S Freedman, D Neuberg, et al.
Bone Marrow Transplantation|December 23, 2015
Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantationI Ahmad, R LeBlanc, S Cohen, et al.
Bone Marrow Transplantation|January 10, 2002
Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effectR Le Blanc, S Montminy-Métivier, R Bélanger, et al.
Leukemia|May 15, 2013
Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic targetJ G Harb, P Neviani, B J Chyla, et al.
Leukemia|February 10, 2016
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancersD P Granados, A Rodenbrock, J-P Laverdure, et al.
Nature Genetics|October 3, 1999
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaW J Song, M G Sullivan, R D Legare, et al.
Pageof 8